Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, announced its executive leadership participation in two upcoming healthcare investor conferences. CEO Mojdeh Poul and CFO Lea Knight will present at the Wells Fargo Healthcare Conference on September 3, 2025, at 12:45 p.m. ET, and the Morgan Stanley Healthcare Conference on September 10, 2025, at 8:30 a.m. ET.
Investors can access live webcasts of both presentations through Integra LifeSciences' investor relations website under the Events & Presentations section.
Details
News Market Reaction – IART
On Sep 2, the first trading day after this news, IART closed 0.20% above the previous close.
Data tracked by StockTitan Argus for the Sep 2 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor healthcare conferences:
- Wells Fargo Healthcare Conference on September 3, 2025, at 12:45 p.m. ET
- Morgan Stanley Healthcare Conference on September 10, 2025, at 8:30 a.m. ET
A live webcast of the presentations will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.